Innovation Pharmaceuticals Provides Development Update on Brilacidin for Inflammatory Bowel Disease
Innovation Pharmaceuticals | October 24, 2017
Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, is pleased to provide a development update for Brilacidin as a promising novel, non-corticosteroid, non-biologic treatment for Inflammatory Bowel Disease (IBD).